Temat: "cardiovascular diseases" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Characterizing the polygenic overlap and shared loci between rheumatoid arthritis and cardiovascular diseases.
Autorzy:: Sun X; Department of Epidemiology, School of Public Health, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
Qian Y; Department of Epidemiology, School of Public Health, Zhejiang Chinese Medical University, Hangzhou, 310053, China.; School of Life Sciences, Westlake University, Hangzhou, 310024, China.
Cheng W; NORMENT, Institute of Clinical Medicine, University of Oslo, Oslo, 0407, Norway.
Ye D; Department of Epidemiology, School of Public Health, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
Liu B; Department of Epidemiology, School of Public Health, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
Zhou D; School of Public Health and the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Wen C; College of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
Andreassen OA; NORMENT, Institute of Clinical Medicine, University of Oslo, Oslo, 0407, Norway. .
Mao Y; Department of Epidemiology, School of Public Health, Zhejiang Chinese Medical University, Hangzhou, 310053, China. .; Pokaż więcej
Źródło:: BMC medicine [BMC Med] 2024 Apr 08; Vol. 22 (1), pp. 152. Date of Electronic Publication: 2024 Apr 08.
Typ publikacji:: Journal Article
MeSH Terms:: Cardiovascular Diseases*/epidemiology
Cardiovascular Diseases*/genetics
Arthritis, Rheumatoid*/genetics
Arthritis, Rheumatoid*/epidemiology
Coronary Artery Disease*/genetics
Heart Failure*
Stroke*/epidemiology
Stroke*/genetics
Humans ; Genome-Wide Association Study/methods ; Genetic Predisposition to Disease/genetics ; Polymorphism, Single Nucleotide/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Real-World Treatment Patterns according to Clinical Practice Guidelines in Patients with Type 2 Diabetes Mellitus and Established Cardiovascular Disease in Korea: Multicenter, Retrospective, Observational Study.
Autorzy:: Yang YS; Division of Endocrinology and Metabolism, Department of Internal Medicine, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Uijeongbu, Korea.
Kim NH; Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
Baek JH; Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Korea.
Ko SH; Division of Endocrinology and Metabolism, Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea.
Son JW; Division of Endocrinology and Metabolism, Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Korea.
Lee SH; Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Rhee SY; Department of Endocrinology and Metabolism, Kyung Hee University Hospital, College of Medicine, Kyung Hee University, Seoul, Korea.
Kim SK; Division of Endocrinology and Metabolism, Department of Internal Medicine, CHA Bundang Medical Center, CHA University, Seongnam, Korea.
Sohn TS; Division of Endocrinology and Metabolism, Department of Internal Medicine, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Uijeongbu, Korea.
Jun JE; Division of Endocrinology and Metabolism, Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, College of Medicine, Kyung Hee University, Seoul, Korea.
Jeong IK; Division of Endocrinology and Metabolism, Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, College of Medicine, Kyung Hee University, Seoul, Korea.
Kim CH; Division of Endocrinology and Metabolism, Department of Internal Medicine, Sejong General Hospital, Bucheon, Korea.
Song K; Division of Endocrinology and Metabolism, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Korea.
Rhee EJ; Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Noh J; Division of Endocrinology and Metabolism, Department of Internal Medicine, Inje University Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea.
Hur KY; Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.; Pokaż więcej
Corporate Authors:: Committee of Clinical Practice Guidelines, Korean Diabetes Association
Źródło:: Diabetes & metabolism journal [Diabetes Metab J] 2024 Mar; Vol. 48 (2), pp. 279-289. Date of Electronic Publication: 2024 Jan 26.
Typ publikacji:: Observational Study; Multicenter Study; Journal Article
MeSH Terms:: Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/epidemiology
Cardiovascular Diseases*/complications
Cardiovascular Diseases*/epidemiology
Cardiovascular Diseases*/chemically induced
Adult ; Humans ; Male ; Aged ; Hypoglycemic Agents/pharmacology ; Retrospective Studies ; Republic of Korea/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: The Effect and Mechanism of Oleanolic Acid in the Treatment of Metabolic Syndrome and Related Cardiovascular Diseases.
Autorzy:: Luo Q; Key Laboratory of Vascular Biology and Translational Medicine, Medical School, Hunan University of Chinese Medicine, Changsha 410208, China.
Wei Y; Key Laboratory of Vascular Biology and Translational Medicine, Medical School, Hunan University of Chinese Medicine, Changsha 410208, China.
Lv X; Key Laboratory for Quality Evaluation of Bulk Herbs of Hunan Province, The School of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, China.
Chen W; Key Laboratory of Vascular Biology and Translational Medicine, Medical School, Hunan University of Chinese Medicine, Changsha 410208, China.
Yang D; Key Laboratory of Vascular Biology and Translational Medicine, Medical School, Hunan University of Chinese Medicine, Changsha 410208, China.
Tuo Q; Key Laboratory of Vascular Biology and Translational Medicine, Medical School, Hunan University of Chinese Medicine, Changsha 410208, China.; Pokaż więcej
Źródło:: Molecules (Basel, Switzerland) [Molecules] 2024 Feb 06; Vol. 29 (4). Date of Electronic Publication: 2024 Feb 06.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Metabolic Syndrome*/drug therapy
Cardiovascular Diseases*/drug therapy
Cardiovascular Diseases*/etiology
Oleanolic Acid*/pharmacology
Oleanolic Acid*/therapeutic use
Metabolic Diseases*
Humans ; Obesity

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Factors influencing hospitalization or emergency department visits and mortality in type 2 diabetes following the onset of new cardiovascular diagnoses in a population-based study.
Autorzy:: Agvall B; Department of Research and Development, Region Halland, Halmstad, Sweden. .; Center for Primary Health Care Research, Department of Clinical Sciences, Lund University, Malmö, Malmö, 202 13, Sweden. .
Jonasson JM; Department of Research and Development, Region Halland, Halmstad, Sweden.; School of Public Health and Community Medicine, University of Gothenburg, Göteborg, Sweden.
Galozy A; Center for Applied Intelligent Systems Research, Halmstad University, Halmstad, Sweden.
Halling A; Center for Primary Health Care Research, Department of Clinical Sciences, Lund University, Malmö, Malmö, 202 13, Sweden.; Pokaż więcej
Źródło:: Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Apr 10; Vol. 23 (1), pp. 124. Date of Electronic Publication: 2024 Apr 10.
Typ publikacji:: Observational Study; Journal Article
MeSH Terms:: Diabetes Mellitus, Type 2*/diagnosis
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/epidemiology
Cardiovascular Diseases*/diagnosis
Cardiovascular Diseases*/epidemiology
Humans ; Emergency Room Visits ; Risk Factors ; Hospitalization

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Cardiovascular risk of veterans' football: An observational cohort study with follow-up.
Autorzy:: Egger F; Institute of Sports and Preventive Medicine, Saarland University, Saarbrücken, Germany.
Schilling T; Institute of Sports and Preventive Medicine, Saarland University, Saarbrücken, Germany.
Baumann S; Institute of Sports and Preventive Medicine, Saarland University, Saarbrücken, Germany.
Meyer T; Institute of Sports and Preventive Medicine, Saarland University, Saarbrücken, Germany.
Scharhag J; Institute of Sports and Preventive Medicine, Saarland University, Saarbrücken, Germany.; Department of Sport and Human Movement Science, Centre for Sport Science and University Sports, Sports Medicine, Exercise Physiology and Prevention, University of Vienna, Wien, Austria.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Apr 05; Vol. 19 (4), pp. e0297951. Date of Electronic Publication: 2024 Apr 05 (Print Publication: 2024).
Typ publikacji:: Observational Study; Journal Article
MeSH Terms:: Cardiovascular Diseases*/diagnosis
Cardiovascular Diseases*/epidemiology
Cardiovascular Diseases*/etiology
Veterans*
Football*
Humans ; Aged ; Adult ; Middle Aged ; Follow-Up Studies ; Biomarkers ; Risk Factors ; Heart Disease Risk Factors ; Natriuretic Peptide, Brain

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Causal associations of particulate matter 2.5 and cardiovascular disease: A two-sample mendelian randomization study.
Autorzy:: Cao Y; Department of Cardiology, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, P. R. China.; Department of Cardiology, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei, P. R. China.
Feng Y; Department of Cardiology, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei, P. R. China.
Xia N; Department of Cardiology, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei, P. R. China.
Zhang J; Department of Cardiology, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, P. R. China.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Apr 05; Vol. 19 (4), pp. e0301823. Date of Electronic Publication: 2024 Apr 05 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Cardiovascular Diseases*/etiology
Cardiovascular Diseases*/genetics
Coronary Artery Disease*/etiology
Coronary Artery Disease*/genetics
Hypertension*
Humans ; Genome-Wide Association Study ; Mendelian Randomization Analysis ; Particulate Matter/adverse effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Associations between sleep duration, sleep disturbance and cardiovascular disease biomarkers among adults in the United States.
Autorzy:: Addo PNO; Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, 915 Greene Street, 29208, Columbia, South Carolina, USA. .
Mundagowa PT; Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, 915 Greene Street, 29208, Columbia, South Carolina, USA.
Zhao L; Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, 915 Greene Street, 29208, Columbia, South Carolina, USA.
Kanyangarara M; Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, 915 Greene Street, 29208, Columbia, South Carolina, USA.
Brown MJ; Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, 915 Greene Street, 29208, Columbia, South Carolina, USA.; Arnold School of Public Health, South Carolina Smart State Center for Healthcare Quality, University of South Carolina, Columbia, South Carolina, USA.; Rural and Minority Health Research Center, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina, USA.; Office for the Study on Aging, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina, USA.
Liu J; Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, 915 Greene Street, 29208, Columbia, South Carolina, USA.; Pokaż więcej
Źródło:: BMC public health [BMC Public Health] 2024 Apr 02; Vol. 24 (1), pp. 947. Date of Electronic Publication: 2024 Apr 02.
Typ publikacji:: Journal Article
MeSH Terms:: Cardiovascular Diseases*/epidemiology
Sleep Wake Disorders*/epidemiology
Adult ; Humans ; United States/epidemiology ; Nutrition Surveys ; Sleep Duration ; Glycated Hemoglobin ; Blood Glucose/metabolism ; Biomarkers ; C-Reactive Protein/analysis ; Sleep ; Insulin ; Lipoproteins, HDL ; Triglycerides ; Risk Factors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Pubertal timing: A life course pathway linking early life risk to adulthood cardiometabolic health.
Autorzy:: Bleil ME; Child, Family, & Population Health Nursing, University of Washington, Seattle, WA, United States of America.
Appelhans BM; Department of Preventive Medicine, Rush University Medical Center, Chicago, IL, United States of America.
Gregorich SE; Department of Medicine, University of California San Francisco, San Francisco, CA, United States of America.
Hiatt RA; Department of Epidemiology & Biostatistics, University of California, San Francisco, San Francisco, CA, United States of America.
Roisman GI; Institute of Child Development, University of Minnesota, Minneapolis, MN, United States of America.
Booth-LaForce C; Child, Family, & Population Health Nursing, University of Washington, Seattle, WA, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Mar 27; Vol. 19 (3), pp. e0299433. Date of Electronic Publication: 2024 Mar 27 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Puberty*/physiology
Cardiovascular Diseases*/epidemiology
Cardiovascular Diseases*/etiology
Adult ; Adolescent ; Humans ; Female ; Life Change Events ; Menarche ; Body Mass Index

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Highlighting the effects of high-intensity interval training on the changes associated with hypertrophy, apoptosis, and histological proteins of the heart of old rats with type 2 diabetes.
Autorzy:: Rami M; Department of Sport Physiology, Faculty of Sport Sciences, Shahid Chamran University of Ahvaz, Ahvaz, Iran. .
Ahmadi Hekmatikar A; Department of Physical Education and Sport Sciences, Faculty of Humanities, Tarbiat Modares University, Tehran, 10600, Iran.
Rahdar S; Department of Basic Sciences, Histology Section, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran.
Marashi SS; Department of Sport Physiology, Faculty of Sport Sciences, Shahid Chamran University of Ahvaz, Ahvaz, Iran.
Daud DMA; Health Through Exercise and Active Living (HEAL) Research Unit, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Kota Kinabalu, 88400, Sabah, Malaysia. .; Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, University Malaysia Sabah, Jalan UMS, Kota Kinabalu, 88450, Sabah, Malaysia. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Mar 26; Vol. 14 (1), pp. 7133. Date of Electronic Publication: 2024 Mar 26.
Typ publikacji:: Journal Article
MeSH Terms:: Diabetes Mellitus, Type 2*
High-Intensity Interval Training*/methods
Cardiovascular Diseases*
Humans ; Rats ; Animals ; Aged ; Insulin-Like Growth Factor I ; Proto-Oncogene Proteins c-akt ; Myocytes, Cardiac ; Apoptosis ; Fibrosis ; Hypertrophy ; Phosphatidylinositol 3-Kinases

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Cardiovascular risk factors among nurses: A global systematic review and meta-analysis.
Autorzy:: Khani S; Student Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Rafiei S; Social Determinants of Health Research Center, Research Institute for Prevention of Non-Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran.
Ghashghaee A; The School of Medicine, Dentistry & Nursing, University of Glasgow, Glasgow, United Kingdom.
Masoumi M; Clinical Research and Development Center, Qom University of Medical Sciences, Qom, Iran.
Rezaee S; Instructor Clinical Care Research Center, Research Institute for Health Development, Faculty of Nursing and Midwifery, Kurdistan University of Medical Sciences, Sanandaj, Iran.
Kheradkhah G; Student Research Committee, School of Nursing and Midwifery, Iran University of Medical Sciences, Tehran, Iran.
Abdollahi B; Student Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Mar 21; Vol. 19 (3), pp. e0286245. Date of Electronic Publication: 2024 Mar 21 (Print Publication: 2024).
Typ publikacji:: Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:: Cardiovascular Diseases*/epidemiology
Cardiovascular Diseases*/etiology
Humans ; Risk Factors ; Overweight ; Blood Pressure/physiology ; Heart Disease Risk Factors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomes.
Autorzy:: Schnell O; Forschergruppe Diabetes e. V, Helmholtz Center Munich, Ingolstaedter Landstraße 1, 85764, Neuherberg (Munich), Germany. .
Barnard-Kelly K; Southern Health NHS Foundation Trust, Southampton, United Kingdom.
Battelino T; University Medical Center, Ljubljana, Slovenia.; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Ceriello A; IRCCS MultiMedica, Milan, Italy.
Larsson HE; Department of Pediatrics, Skåne University Hospital, Malmö/Lund, Sweden.; Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.
Fernández-Fernández B; Division of Nephrology and Hypertension, University Hospital Fundación Jiménez Díaz, Madrid, Spain.
Forst T; CRS Clinical Research Services Mannheim GmbH, Mannheim, Germany.
Frias JP; Biomea Fusion, Redwood City, CA, United States of America.
Gavin JR 3rd; Emory University School of Medicine, Atlanta, GA, United States of America.
Giorgino F; Department of Precision and Regenerative Medicine and Ionian Area, University of Bari Aldo Moro, Bari, Italy.
Groop PH; Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Department of Diabetes, Central Medical School, Monash University, Melbourne, Australia.
Heerspink HJL; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Herzig S; Division Diabetic Complications, Institute for Diabetes and Cancer, Helmholtz Center Munich, Neuherberg, Germany.
Hummel M; Forschergruppe Diabetes e. V, Helmholtz Center Munich, Ingolstaedter Landstraße 1, 85764, Neuherberg (Munich), Germany.
Huntley G; Diabetes Leadership Council, Indianapolis, IN, United States of America.
Ibrahim M; Center for Diabetes Education, EDC, Charlotte, NC, United States of America.
Itzhak B; Clalit Health Services, Haifa, Israel.; Technion Faculty of Medicine, Haifa, Israel.
Jacob S; Practice for Prevention and Therapy and Cardio-Metabolic Institute, Villingen-Schwenningen, Germany.
Ji L; Peking University People's Hospital, Xicheng District, Beijing, China.
Kosiborod M; Department of Cardiovascular Disease, Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City School of Medicine, Kansas City, MO, United States of America.
Lalic N; Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center of Serbia, Belgrade, Serbia.; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Macieira S; Sciarc GmbH, Baierbrunn, Germany.
Malik RA; Weill Cornell Medicine-Qatar, Qatar Foundation-Education City, Ar-Rayyan, Doha, Qatar.
Mankovsky B; Shupyk National Healthcare University of Ukraine, Kyiv, Ukraine.
Marx N; Clinic for Cardiology, Pneumology, Angiology and Internal Intensive Care Medicine (Medical Clinic I), RWTH Aachen University Hospital, Aachen, Germany.
Mathieu C; Department of Endocrinology, Catholic University Leuven, Leuven, Belgium.
Müller TD; Institute for Diabetes and Obesity, Helmholtz Munich, Munich, Germany.; Walther-Straub Institute for Pharmacology and Toxicology, Ludwig-Maximilians-University Munich (LMU), Munich, Germany.
Ray K; School of Public Health, Imperial College London, London, United Kingdom.
Rodbard HW; Endocrine and Metabolic Consultants, Rockville, MD, United States of America.
Rossing P; Steno Diabetes Center Copenhagen, Herlev, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Rydén L; Department of Medicine K2, Karolinska Institute, Stockholm, Sweden.
Schumm-Draeger PM; Center Internal Medicine Fünf Höfe, Munich, Germany.
Schwarz P; Medical Clinic III, University Hospital Carl Gustav Carus, Dresden, Germany.
Škrha J; Third Medical Department and Laboratory for Endocrinology and Metabolism, First Faculty of Medicine, Charles University, Prague, Czech Republic.
Snoek F; Amsterdam University Medical Centers, Amsterdam, The Netherlands.
Tacke F; Department of Hepatology and Gastroenterology, Charité Universitätsmedizin Berlin, Campus Virchow-Klinikum and Campus Charité Mitte, Berlin, Germany.
Taylor B; Diabetes Patient Advocacy Coalition, Tampa, FL, United States of America.
Jeppesen BT; Future Evidence Foundation, Melbourne, Australia.
Tesfaye S; Sheffield Teaching Hospitals, Sheffield, United Kingdom.; University of Sheffield, Sheffield, United Kingdom.
Topsever P; Department of Family Medicine, Acıbadem Mehmet Ali Aydınlar University School of Medicine, Istanbul, Türkiye.
Vilsbøll T; Steno Diabetes Center Copenhagen, Herlev, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Yu X; Division of Endocrinology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Standl E; Forschergruppe Diabetes e. V, Helmholtz Center Munich, Ingolstaedter Landstraße 1, 85764, Neuherberg (Munich), Germany.; Pokaż więcej
Źródło:: Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Mar 19; Vol. 23 (1), pp. 104. Date of Electronic Publication: 2024 Mar 19.
Typ publikacji:: Letter
MeSH Terms:: Heart Failure*/complications
Cardiovascular Diseases*/diagnosis
Cardiovascular Diseases*/epidemiology
Cardiovascular Diseases*/prevention & control
Renal Insufficiency, Chronic*/diagnosis
Renal Insufficiency, Chronic*/epidemiology
Renal Insufficiency, Chronic*/therapy
Diabetes Mellitus*/drug therapy
Diabetes Mellitus, Type 2*/drug therapy
Humans ; Blood Glucose Self-Monitoring ; Stroke Volume ; Blood Glucose ; Obesity/complications ; Kidney

Opinia redakcyjna

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Association between systemic sclerosis and risk of cerebrovascular and cardiovascular disease: a meta-analysis.
Autorzy:: Chen IW; Department of Anesthesiology, Chi Mei Medical Center, Liouying, Tainan, Taiwan.
Wang WT; Department of Anesthesiology, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan.
Lai YC; Department of Anesthesiology, Chi Mei Medical Center, No. 901, ChungHwa Road, YungKung Dist, Tainan, 71004, Taiwan.
Lin CM; Department of Anesthesiology, Chi Mei Medical Center, No. 901, ChungHwa Road, YungKung Dist, Tainan, 71004, Taiwan.
Liu PH; Department of Anesthesiology, E-Da Dachang Hospital, I-Shou University, Kaohsiung, Taiwan.
Wu SZ; Department of Anesthesiology, Chi Mei Medical Center, Liouying, Tainan, Taiwan.; Department of Nursing, Min-Hwei Junior College of Health Care Management, Tainan, Taiwan.
Hung KC; Department of Anesthesiology, Chi Mei Medical Center, No. 901, ChungHwa Road, YungKung Dist, Tainan, 71004, Taiwan. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Mar 18; Vol. 14 (1), pp. 6445. Date of Electronic Publication: 2024 Mar 18.
Typ publikacji:: Systematic Review; Meta-Analysis; Journal Article
MeSH Terms:: Cardiovascular Diseases*/epidemiology
Cardiovascular Diseases*/etiology
Venous Thromboembolism*
Myocardial Infarction*/epidemiology
Myocardial Infarction*/etiology
Stroke*/epidemiology
Stroke*/etiology
Peripheral Vascular Diseases*/epidemiology
Scleroderma, Systemic*/complications
Scleroderma, Systemic*/epidemiology
Humans

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: The impact of multimorbidity among adults with cardiovascular diseases on healthcare costs in Indonesia: a multilevel analysis.
Autorzy:: Ramadani RV; School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. .; Center for Health Economics and Policy Studies, Faculty of Public Health, Universitas Indonesia, Kota Depok, Indonesia. .
Svensson M; School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville, USA.
Hassler S; Department of Health Sciences, Karlstad University, Karlstad, Sweden.
Hidayat B; Center for Health Economics and Policy Studies, Faculty of Public Health, Universitas Indonesia, Kota Depok, Indonesia.
Ng N; School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Pokaż więcej
Źródło:: BMC public health [BMC Public Health] 2024 Mar 15; Vol. 24 (1), pp. 816. Date of Electronic Publication: 2024 Mar 15.
Typ publikacji:: Journal Article
MeSH Terms:: Multimorbidity*
Cardiovascular Diseases*/epidemiology
Cardiovascular Diseases*/therapy
Adult ; Humans ; Retrospective Studies ; Indonesia/epidemiology ; Multilevel Analysis ; Health Care Costs

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Mendelian randomization study on insulin resistance and risk of hypertension and cardiovascular disease.
Autorzy:: Zhang F; Department of Outpatient, Taihe Hospital, Hubei University of Medicine, Shiyan, 442000, Hubei, China.
Yu Z; Department of Geriatrics, Taihe Hospital, Hubei University of Medicine, Shiyan, 442000, China. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Mar 14; Vol. 14 (1), pp. 6191. Date of Electronic Publication: 2024 Mar 14.
Typ publikacji:: Meta-Analysis; Journal Article
MeSH Terms:: Cardiovascular Diseases*/epidemiology
Cardiovascular Diseases*/genetics
Insulin Resistance*/genetics
Atrial Fibrillation*/genetics
Venous Thromboembolism*
Hypertension*/genetics
Heart Failure*/genetics
Peripheral Arterial Disease*
Hyperinsulinism*
Aortic Aneurysm*
Humans ; Mendelian Randomization Analysis ; Genome-Wide Association Study ; Polymorphism, Single Nucleotide

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Impact of genetic background as a risk factor for atherosclerotic cardiovascular disease: A protocol for a nationwide genetic case-control (CV-GENES) study in Brazil.
Autorzy:: Alves de Oliveira H Junior; Sustainability and Social Responsibility, Hospital Alemão Oswaldo Cruz, São Paulo, São Paulo, Brazil.
de Menezes Neves PDM; International Research Center, Hospital Alemão Oswaldo Cruz, São Paulo, São Paulo, Brazil.
de Figueiredo Oliveira GB; International Research Center, Hospital Alemão Oswaldo Cruz, São Paulo, São Paulo, Brazil.
Moreira FR; Sustainability and Social Responsibility, Hospital Alemão Oswaldo Cruz, São Paulo, São Paulo, Brazil.
Pintão MCT; Department of Research and Development, Fleury Group, São Paulo, São Paulo, Brazil.
Rocha VZ; Department of Research and Development, Fleury Group, São Paulo, São Paulo, Brazil.
de Souza Rocha C; Department of Research and Development, Fleury Group, São Paulo, São Paulo, Brazil.
Katz VN; Department of Research and Development, Fleury Group, São Paulo, São Paulo, Brazil.
Ferreira EN; Department of Research and Development, Fleury Group, São Paulo, São Paulo, Brazil.
Rojas-Málaga D; Department of Research and Development, Fleury Group, São Paulo, São Paulo, Brazil.
Viana CF; Department of Research and Development, Fleury Group, São Paulo, São Paulo, Brazil.
da Silva FF; International Research Center, Hospital Alemão Oswaldo Cruz, São Paulo, São Paulo, Brazil.
Vidotti JJ; International Research Center, Hospital Alemão Oswaldo Cruz, São Paulo, São Paulo, Brazil.
Felicio NM; International Research Center, Hospital Alemão Oswaldo Cruz, São Paulo, São Paulo, Brazil.
de Araújo Vitor L; Sustainability and Social Responsibility, Hospital Alemão Oswaldo Cruz, São Paulo, São Paulo, Brazil.
Cesar KG; Sustainability and Social Responsibility, Hospital Alemão Oswaldo Cruz, São Paulo, São Paulo, Brazil.
Araújo da Silva C; Sustainability and Social Responsibility, Hospital Alemão Oswaldo Cruz, São Paulo, São Paulo, Brazil.
de Oliveira Alves LB; Sustainability and Social Responsibility, Hospital Alemão Oswaldo Cruz, São Paulo, São Paulo, Brazil.
Avezum Á; International Research Center, Hospital Alemão Oswaldo Cruz, São Paulo, São Paulo, Brazil.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Mar 13; Vol. 19 (3), pp. e0289439. Date of Electronic Publication: 2024 Mar 13 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Cardiovascular Diseases*/epidemiology
Cardiovascular Diseases*/genetics
Cardiovascular Diseases*/prevention & control
Atherosclerosis*/genetics
Atherosclerosis*/epidemiology
Humans ; Proprotein Convertase 9 ; Case-Control Studies ; Brazil/epidemiology ; Risk Factors ; Genetic Background ; Multicenter Studies as Topic

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Underlying mechanisms and cardioprotective effects of SGLT2i and GLP-1Ra: insights from cardiovascular magnetic resonance.
Autorzy:: Cersosimo A; Department of Experimental and Clinical Medicine, Magna Graecia University, Catanzaro, Italy.
Salerno N; Department of Experimental and Clinical Medicine, Magna Graecia University, Catanzaro, Italy.
Sabatino J; Department of Experimental and Clinical Medicine, Magna Graecia University, Catanzaro, Italy.
Scatteia A; Advanced Cardiovascular Imaging Unit, Ospedale Medico-Chirurgico Accreditato Villa dei Fiori, Naples, Italy.
Bisaccia G; Department of Neuroscience, Imaging and Clinical Sciences, Institute for Advanced Biomedical Technologies 'G. d'Annunzio', University of Chieti-Pescara, Chieti, Italy.
De Rosa S; Department of Medical and Surgical Sciences, Magna Graecia University, Catanzaro, Italy.
Dellegrottaglie S; Advanced Cardiovascular Imaging Unit, Ospedale Medico-Chirurgico Accreditato Villa dei Fiori, Naples, Italy.
Bucciarelli-Ducci C; CMR Unit, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.; School of Biomedical Engineering and Imaging Sciences, Faculty of Life Sciences and Medicine, Kings College London, London, UK.
Torella D; Department of Experimental and Clinical Medicine, Magna Graecia University, Catanzaro, Italy. .
Leo I; Department of Experimental and Clinical Medicine, Magna Graecia University, Catanzaro, Italy. .; Pokaż więcej
Źródło:: Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Mar 11; Vol. 23 (1), pp. 94. Date of Electronic Publication: 2024 Mar 11.
Typ publikacji:: Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:: Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use
Cardiovascular System*
Diabetes Mellitus, Type 2*
Cardiovascular Diseases*/diagnostic imaging
Cardiovascular Diseases*/prevention & control
Humans ; Magnetic Resonance Imaging ; Magnetic Resonance Spectroscopy ; Glucagon-Like Peptide-1 Receptor ; Hypoglycemic Agents/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Cardiovascular Risk Factors in Adolescents with Type 1 Diabetes: Prevalence and Gender Differences
Autorzy:: Vurallı D; Hacettepe University Faculty of Medicine, Department of Pediatrics, Clinic of Pediatric Endocrinology, Ankara, Turkey
Jalilova L; Hacettepe University Faculty of Medicine, Department of Pediatrics, Ankara, Turkey
Alikaşifoğlu A; Hacettepe University Faculty of Medicine, Department of Pediatrics, Clinic of Pediatric Endocrinology, Ankara, Turkey
Özön ZA; Hacettepe University Faculty of Medicine, Department of Pediatrics, Clinic of Pediatric Endocrinology, Ankara, Turkey
Gönç EN; Hacettepe University Faculty of Medicine, Department of Pediatrics, Clinic of Pediatric Endocrinology, Ankara, Turkey
Kandemir N; Hacettepe University Faculty of Medicine, Department of Pediatrics, Clinic of Pediatric Endocrinology, Ankara, Turkey; Pokaż więcej
Źródło:: Journal of clinical research in pediatric endocrinology [J Clin Res Pediatr Endocrinol] 2024 Mar 11; Vol. 16 (1), pp. 11-20. Date of Electronic Publication: 2023 Aug 10.
Typ publikacji:: Journal Article
MeSH Terms:: Diabetes Mellitus, Type 1*/epidemiology
Diabetes Mellitus, Type 1*/complications
Cardiovascular Diseases*/epidemiology
Cardiovascular Diseases*/etiology
Hypertension*/epidemiology
Hypertension*/complications
Insulins*
Child ; Humans ; Female ; Adolescent ; Male ; Risk Factors ; Cholesterol, LDL ; Prevalence ; Sex Characteristics ; Sex Factors ; Obesity ; Overweight/epidemiology ; Overweight/complications ; Body Mass Index ; Heart Disease Risk Factors

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: The Roles of Exosome-Derived microRNAs in Cardiac Fibrosis.
Autorzy:: Tang X; Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Guangzhou 510006, China.; Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China, Guangzhou 510006, China.; Guangdong Key Laboratory of Metabolic Disease Prevention and Treatment of Traditional Chinese Medicine, Guangzhou 510006, China.; Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Leng M; Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Guangzhou 510006, China.; Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China, Guangzhou 510006, China.; Guangdong Key Laboratory of Metabolic Disease Prevention and Treatment of Traditional Chinese Medicine, Guangzhou 510006, China.; Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Tang W; Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Guangzhou 510006, China.; Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China, Guangzhou 510006, China.; Guangdong Key Laboratory of Metabolic Disease Prevention and Treatment of Traditional Chinese Medicine, Guangzhou 510006, China.; Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Cai Z; Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Guangzhou 510006, China.; Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China, Guangzhou 510006, China.; Guangdong Key Laboratory of Metabolic Disease Prevention and Treatment of Traditional Chinese Medicine, Guangzhou 510006, China.; Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Yang L; Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Guangzhou 510006, China.; Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China, Guangzhou 510006, China.; Guangdong Key Laboratory of Metabolic Disease Prevention and Treatment of Traditional Chinese Medicine, Guangzhou 510006, China.; Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Wang L; Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Guangzhou 510006, China.; Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China, Guangzhou 510006, China.; Guangdong Key Laboratory of Metabolic Disease Prevention and Treatment of Traditional Chinese Medicine, Guangzhou 510006, China.; Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Zhang Y; Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Guangzhou 510006, China.; Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China, Guangzhou 510006, China.; Guangdong Key Laboratory of Metabolic Disease Prevention and Treatment of Traditional Chinese Medicine, Guangzhou 510006, China.; Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Guo J; Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Guangzhou 510006, China.; Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China, Guangzhou 510006, China.; Guangdong Key Laboratory of Metabolic Disease Prevention and Treatment of Traditional Chinese Medicine, Guangzhou 510006, China.; Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou 510006, China.; Pokaż więcej
Źródło:: Molecules (Basel, Switzerland) [Molecules] 2024 Mar 07; Vol. 29 (6). Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:: Journal Article; Review
MeSH Terms:: MicroRNAs*/genetics
MicroRNAs*/metabolism
Exosomes*/genetics
Exosomes*/metabolism
Cardiovascular Diseases*/metabolism
Humans ; Cell Communication ; Fibrosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Noise annoyance and cardiovascular disease risk: results from a 10-year follow-up study.
Autorzy:: Hahad O; Department of Cardiology, Cardiology I, University Medical Center of the Johannes Gutenberg University Mainz, Langenbeckstraße 1, 55131, Mainz, Germany. .; German Center for Cardiovascular Research (DZHK), Partner Site Rhine-Main, Mainz, Germany. .
Gilan D; Leibniz Institute for Resilience Research (LIR), Mainz, Germany.; Department of Psychiatry and Psychotherapy, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Michal M; German Center for Cardiovascular Research (DZHK), Partner Site Rhine-Main, Mainz, Germany.; Department of Psychosomatic Medicine and Psychotherapy, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Tüscher O; Leibniz Institute for Resilience Research (LIR), Mainz, Germany.; Department of Psychiatry and Psychotherapy, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.; Institute for Molecular Biology, Mainz, Germany.
Chalabi J; Preventive Cardiology and Preventive Medicine, Department of Cardiology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Schuster AK; Department of Ophthalmology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Keller K; Department of Cardiology, Cardiology I, University Medical Center of the Johannes Gutenberg University Mainz, Langenbeckstraße 1, 55131, Mainz, Germany.; Center for Thrombosis and Hemostasis (CTH), University Medical Center Mainz (Johannes Gutenberg-University Mainz), Mainz, Germany.; Medical Clinic VII, Department of Sports Medicine, University Hospital Heidelberg, Heidelberg, Germany.
Hobohm L; Department of Cardiology, Cardiology I, University Medical Center of the Johannes Gutenberg University Mainz, Langenbeckstraße 1, 55131, Mainz, Germany.; Center for Thrombosis and Hemostasis (CTH), University Medical Center Mainz (Johannes Gutenberg-University Mainz), Mainz, Germany.
Schmitt VH; Department of Cardiology, Cardiology I, University Medical Center of the Johannes Gutenberg University Mainz, Langenbeckstraße 1, 55131, Mainz, Germany.; German Center for Cardiovascular Research (DZHK), Partner Site Rhine-Main, Mainz, Germany.
König J; Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Lackner KJ; Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Wild P; German Center for Cardiovascular Research (DZHK), Partner Site Rhine-Main, Mainz, Germany.; Institute for Molecular Biology, Mainz, Germany.; Preventive Cardiology and Preventive Medicine, Department of Cardiology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.; Center for Thrombosis and Hemostasis (CTH), University Medical Center Mainz (Johannes Gutenberg-University Mainz), Mainz, Germany.
Schattenberg JM; Metabolic Liver Research Program, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.; Department of Internal Medicine II, Saarland University Medical Center, Homburg, Germany.
Daiber A; Department of Cardiology, Cardiology I, University Medical Center of the Johannes Gutenberg University Mainz, Langenbeckstraße 1, 55131, Mainz, Germany.; German Center for Cardiovascular Research (DZHK), Partner Site Rhine-Main, Mainz, Germany.; Center for Thrombosis and Hemostasis (CTH), University Medical Center Mainz (Johannes Gutenberg-University Mainz), Mainz, Germany.
Münzel T; Department of Cardiology, Cardiology I, University Medical Center of the Johannes Gutenberg University Mainz, Langenbeckstraße 1, 55131, Mainz, Germany.; German Center for Cardiovascular Research (DZHK), Partner Site Rhine-Main, Mainz, Germany.; Center for Thrombosis and Hemostasis (CTH), University Medical Center Mainz (Johannes Gutenberg-University Mainz), Mainz, Germany.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Mar 07; Vol. 14 (1), pp. 5619. Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:: Journal Article
MeSH Terms:: Cardiovascular Diseases*/epidemiology
Cardiovascular Diseases*/etiology
Humans ; Follow-Up Studies ; Cohort Studies ; Prospective Studies ; Cross-Sectional Studies ; Risk Factors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Photodynamic Therapy and Cardiovascular Diseases.
Autorzy:: Oskroba A; Science Club, Faculty of Medicine, Medical University of Lublin, 20-059 Lublin, Poland.
Bartusik-Aebisher D; Department of Biochemistry and General Chemistry, Medical College of The Rzeszów University, 35-959 Rzeszów, Poland.
Myśliwiec A; Center for Innovative Research in Medical and Natural Sciences, Medical College of the University of Rzeszów, 35-310 Rzeszów, Poland.
Dynarowicz K; Center for Innovative Research in Medical and Natural Sciences, Medical College of the University of Rzeszów, 35-310 Rzeszów, Poland.
Cieślar G; Department of Internal Medicine, Angiology and Physical Medicine, Center for Laser Diagnostics and Therapy, Medical University of Silesia in Katowice, Batorego 15 St., 41-902 Bytom, Poland.
Kawczyk-Krupka A; Department of Internal Medicine, Angiology and Physical Medicine, Center for Laser Diagnostics and Therapy, Medical University of Silesia in Katowice, Batorego 15 St., 41-902 Bytom, Poland.
Aebisher D; Department of Photomedicine and Physical Chemistry, Medical College of The Rzeszów University, 35-959 Rzeszów, Poland.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 04; Vol. 25 (5). Date of Electronic Publication: 2024 Mar 04.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Photochemotherapy*/methods
Cardiovascular Diseases*/drug therapy
Neoplasms*/drug therapy
Humans ; Photosensitizing Agents/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""cardiovascular diseases"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Rok publikacji